100 beauty industry changemakers are invited to Core Biogenesis’ exclusive webinar on June 25. This is the second in the series, following the first, which aired on June 18 for the first 100 guests. While webinars are well-established as valuable learning tools, the urgency that accompanies one of this magnitude rests in the limited number of spaces available for those to be among the first to access this groundbreaking data on oleosome-growth factor technology and 0.3% retinol. Having the edge on this information can set attendees apart from their competition and give trailblazers the information they need to pioneer new approaches in tackling well-aging.
0.3% retinol is the current standard for well-aging and is the highest dose currently allowed. The in-vitro data presented features Peauvita and Peauforia, next-generation growth factor ingredients fused to Camelina oleosomes. This webinar demonstrates a more effective and stable alternative to retinol that may transform the way the industry ages. Attendees will see wrinkles and fine lines visibly reduced in 2 weeks through growth factors that can be up to 10x more stable while penetrating deeper into the skin. This new era of performance is denoted by its plant biotechnology foundation.
“Our mission is to make biotechnology accessible to every skin care brand, especially the rising indie innovators shaping the future of beauty,” says Tony Abboud, CCO for Core Biogenesis. “We’re excited to connect with founders and formulators and show what’s truly possible in just two weeks.”
Core Biogenesis is a French biotechnology company changing the way the beauty industry uses high-performance growth factors. Using its plant biofactory technology, Core Biogenesis creates stable, deep-penetrating growth factors, fusing them to oleosomes from plant seed oils and vitamin E. In targeting stability and delivery, Core Biogenesis is transforming the very foundation of today’s cosmetic science.
